Kazia Therapeutics licenses SETDB1 drug platform for $1.39 million

Go back to Kazia Therapeutics licenses SETDB1 drug platform for $1.39 million
(NASDAQ: KZIA) Delayed: 14.69 +0.69 (4.93%)
Previous Close $14.00    52 Week High
Open $13.83    52 Week Low
Day High $15.07    P/E N/A 
Day Low $13.83    EPS
Volume 168,194